RNA editing as a therapeutic target for CNS disorders

被引：15
|
作者：
Morabito, Michael V. [1 ,2 ]
Emeson, Ronald B. [1 ,2 ]
机构：
[1] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Ctr Mol Neursci, Nashville, TN USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2009年 / 34卷 / 01期
关键词：
RECEPTOR; SUICIDE; GLUR2;
D O I：
10.1038/npp.2008.159
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [31] Integrated Stress Response as a Therapeutic Target for CNS Injuries
    Romero-Ramirez, Lorenzo
    Nieto-Sampedro, Manuel
    Asuncion Barreda-Manso, M.
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [32] VEGFA- a New Therapeutic Target in CNS Leukemia
    Kato, Itaru
    Nishinaka-Arai, Yoko
    Nakamura, Masahiro
    Akarca, Ayse U.
    Niwa, Akira
    Ozawa, Hiroki
    Yoshida, Kenichi
    Mori, Makiko
    Wang, Dapeng
    Ueno, Hiroo
    Shiozawa, Yusuke
    Shiraishi, Yuichi
    Miyano, Satoru
    Gupta, Rajeev
    Umeda, Katsutsugu
    Watanabe, Kenichiro
    Koh, Katsuyoshi
    Adachi, Souichi
    Heike, Toshio
    Saito, Megumu K.
    Sanada, Masashi
    Ogawa, Seishi
    Marafioti, Teresa
    Watanabe, Akira
    Nakahata, Tatsutoshi
    Enver, Tariq
    BLOOD, 2016, 128 (22)
  • [33] Glutamate in CNS disorders as a target for drug development: An update
    Parsons, CG
    Danysz, W
    Quack, G
    DRUG NEWS & PERSPECTIVES, 1998, 11 (09) : 523 - 569
  • [34] RNA editing in cancer: Mechanistic, prognostic, and therapeutic implications
    Han, Leng
    Liang, Han
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [35] Recent Therapeutic Gene Editing Applications to Genetic Disorders
    Deneault, Eric
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (05) : 4147 - 4185
  • [36] THERAPEUTIC GENOME EDITING FOR SEVERE MONOGENIC SKIN DISORDERS
    Hunt, J. M.
    du Rand, A.
    Dunbar, P. R.
    Knapp, D.
    Purvis, D.
    Feisst, V.
    Sheppard, H.
    CYTOTHERAPY, 2024, 26 (06) : S28 - S28
  • [37] The Role of RNA Editing in Cancer Development and Metabolic Disorders
    Kung, Che-Pei
    Maggi, Leonard B., Jr.
    Weber, Jason D.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [38] ANIMAL MODELS OF CNS DISORDERS: IMPLICATIONS FOR THERAPEUTIC APPROACHES
    Caron, M. G.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 67 - 67
  • [39] Therapeutic potential of potassium channel modulators for CNS disorders
    Clark, AG
    Booth, SE
    Morrow, JA
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (01) : 23 - 32
  • [40] MEDI 239-Histamine H3 receptor as a therapeutic drug target for multiple CNS disorders
    Renger, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
12345